TGFB1 and neoplasm: TGF-β signaling inhibits neutrophil cytotoxicity and reactive oxygen species (ROS) production, while promoting the expression of matrix metalloproteinases MMP - 9 and vascular endothelial growth factor (VEGF) (76–79), thereby enhancing tumor angiogenesis and extracellular matrix remodeling.